Sílvia Marinho Martins Alves, Bárbara Mariana dos Santos Silva, Esthefany Dias Barbosa, C. Medeiros, M. D. N. D. S. Barros, M. Cavalcanti, Maria Elisa Lucena Sales de Melo Assunção, Virginia Lorena, A. Albuquerque, Renata Amorim de Lucena, C. Montenegro, C. B. Pereira, Lucas Reis da Costa, C. Carrazzone, W. Oliveira
{"title":"Advances in Clinical Practice, Diagnosis and Treatment of Chronic Chagas’ Heart Disease","authors":"Sílvia Marinho Martins Alves, Bárbara Mariana dos Santos Silva, Esthefany Dias Barbosa, C. Medeiros, M. D. N. D. S. Barros, M. Cavalcanti, Maria Elisa Lucena Sales de Melo Assunção, Virginia Lorena, A. Albuquerque, Renata Amorim de Lucena, C. Montenegro, C. B. Pereira, Lucas Reis da Costa, C. Carrazzone, W. Oliveira","doi":"10.36660/abchf.20230029","DOIUrl":null,"url":null,"abstract":"Chagas disease has become globalized as a result of the migratory process of infected patients to non-endemic areas. With the considerable number of individuals affected by the disease, detection and treatment of its chronic manifestations is a relevant and necessary issue. Growing attention has been paid to chronic Chagas cardiomyopathy (CCC), which includes heart failure, malignant arrhythmias, conduction disturbances and thromboembolic events. Many pharmacological and non-pharmacological treatments for CCC are still extrapolations of existing evidence on the treatment of other clinical conditions, highlighting the need of including this group of patients in future studies. In this review, we will discuss the most recent data from the literature and clinical practice on the diagnosis and treatment of CCC.","PeriodicalId":231546,"journal":{"name":"ABC Heart Fail Cardiomyop","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ABC Heart Fail Cardiomyop","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36660/abchf.20230029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Chagas disease has become globalized as a result of the migratory process of infected patients to non-endemic areas. With the considerable number of individuals affected by the disease, detection and treatment of its chronic manifestations is a relevant and necessary issue. Growing attention has been paid to chronic Chagas cardiomyopathy (CCC), which includes heart failure, malignant arrhythmias, conduction disturbances and thromboembolic events. Many pharmacological and non-pharmacological treatments for CCC are still extrapolations of existing evidence on the treatment of other clinical conditions, highlighting the need of including this group of patients in future studies. In this review, we will discuss the most recent data from the literature and clinical practice on the diagnosis and treatment of CCC.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
